Home Newsfeeds Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $128

Morgan Stanley Maintains Overweight on iRhythm Technologies, Lowers Price Target to $128

Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $165 to $128.

January 6, 2023

1 minute read

Morgan Stanley analyst Cecilia Furlong maintains iRhythm Technologies (NASDAQ:IRTC) with a Overweight and lowers the price target from $165 to $128.

Fed’s Bullard Says He Thinks U.S. GDP Will Be Revised Higher For First Half Of The Year At Some Point But Too Late To Be Useful For Monetary Policy; U.S. GDP Probably Was Really Flat In First Half Of The Year, Not Negative, Q3 Looks To Be Positive

Yesterday, 3:51 PM

- Reuters

January 31, 8:57 AM

Honeywell International Inc. (NASDAQ: HON) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 1, 2024.

January 30, 2:25 PM

Benchmark analyst Mark Zgutowicz remained Hold-rated on Meta Platforms Inc (NASDAQ:META) before Meta’s 4Q report. The analyst did not see enough ’23…

March 23, 10:48 AM

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the…